Rosuvastatin Calcium Market |Capsule to be Largest Revenue-Generating Application Segment – Market.us
Pune, Maharashtra, India, October 18 2022 (Wiredrelease) Prudour Pvt. Ltd --:The global rosuvastatin calcium market is expected to grow at a CAGR of 5.9% during the forecast period. Rosuvastatin calcium is an oral drug used for the treatment of dyslipidemia and prevention of cardiovascular diseases. The major drivers for the growth of this market are increase in prevalence of cardiovascular diseases, rising geriatric population, and favorable reimbursement policies. However, stringent regulations related to drug approvals are restraining the growth of this market. Rosuvastatin calcium belongs to the class of statins, which are inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. This…
- Date: October 18, 2022
- Author: Quintero
- Category: PharmiWeb